| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 28, 2006
Accepted on December 15, 2006
-cell: SCHAD regulates insulin secretion independent of K+ currents
Department of Genetics, Department of Biochemistry and Biophysics University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, 19104; Sarah W. Stedman Nutrition and Metabolism Center and Departments of Pharmacology and Cancer Biology and Medicine, Duke University Medical Center, Durham, North Carolina, 27704; Computational Biology and Informatics Laboratory, Philadelphia, University of Pennsylvania, 19104
* To whom correspondence should be addressed. E-mail: kaestner{at}mail.med.upenn.edu.
Recent advances in functional genomics afford the opportunity to interrogate the expression profiles of thousands of genes simultaneously and examine the function of these genes in a high throughput manner. In this study, we describe a rational and efficient approach to identifying novel regulators of insulin secretion by the pancreatic
-cell. Computational analysis of expression profiles of several mouse and cellular models of impaired insulin secretion identified 373 candidate genes involved in regulation of insulin secretion. Using RNA interference, we assessed the requirements of ten of these candidates and identified four genes (40%) as being essential for normal insulin secretion. Among the genes identified was short-chain L-3-hydroxyacyl-CoA dehydrogenase (Hadhsc), which encodes SCHAD, an enzyme of mitochondrial
-oxidation of fatty acids whose mutation results in congenital hyperinsulinism. RNAi mediated gene suppression of Hadhsc in insulinoma cells and primary rodent islets revealed enhanced basal but normal glucose stimulated insulin secretion. This increase in basal insulin secretion was not attenuated by opening of the KATP channel with diazoxide, suggesting that SCHAD regulates insulin secretion through a KATP channel independent mechanism. Our results suggest a molecular explanation for the hyperinsulinemia hypoglycemic seen in patients with SCHAD deficiency.
This article has been cited by other articles:
![]() |
G. A. Martens, A. Vervoort, M. Van de Casteele, G. Stange, K. Hellemans, H. V. Van Thi, F. Schuit, and D. Pipeleers Specificity in Beta Cell Expression of L-3-Hydroxyacyl-CoA Dehydrogenase, Short Chain, and Potential Role in Down-regulating Insulin Release J. Biol. Chem., July 20, 2007; 282(29): 21134 - 21144. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |